NCT03200132

Brief Summary

This study evaluates the possibility of Magnetic Resonance Imaging (MRI) based respiratory motion correction of simultaneously acquired cardiac Positron Emission Tomography (PET) images.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jun 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

June 26, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 27, 2017

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 14, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2021

Completed
Last Updated

April 8, 2022

Status Verified

April 1, 2022

Enrollment Period

4.3 years

First QC Date

June 26, 2017

Last Update Submit

April 7, 2022

Conditions

Cardiac Imaging

Outcome Measures

Primary Outcomes (1)

  • Target-to-background ratio (TBR)

    15-20 minutes

Secondary Outcomes (1)

  • Signal-to-noise ratio (SNR)

    15-20 minutes

Interventions

Cardiac PET/MRIDIAGNOSTIC_TEST

For patients undergoing 18-Fluor- fluorodeoxyglucose (18F-FDG) PET/MRI or PET/Computed Tomography (CT), additional cardiac PET/MRI scans are acquired.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients receiving 18F-FDG for clinical diagnostic PET/MRI or PET/CT.

You may qualify if:

  • F-FDG injection for clinical diagnostic PET/MRI or PET/CT

You may not qualify if:

  • Diet-suppressed myocardial uptake of 18F-FDG
  • Not willing to be informed about incidental findings

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maastricht University Hospital

Maastricht, Limburg, 6229HX, Netherlands

Location

Study Officials

  • Joachim Wildberger, MD PhD

    Maastricht University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2017

First Posted

June 27, 2017

Study Start

June 26, 2017

Primary Completion

October 14, 2021

Study Completion

October 14, 2021

Last Updated

April 8, 2022

Record last verified: 2022-04

Locations

NL(1)